A groundbreaking nasal spray using a form of ketamine to treat stubborn depression is set to become more accessible and affordable for thousands of Australians. The spray, known as Spravato, will be ...

The Pharmaceutical Benefits Scheme (PBS) has introduced a groundbreaking treatment for Australians suffering from treatment-resistant depression. Starting May 1, Spravato, a ketamine-based nasal spray ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The federal government has bankrolled the use of an artificial ketamine nasal spray to combat treatment-resistant depression, ...

A controversial substance once tied to underground rave culture is now being hailed as a breakthrough for depression.

The nasal vaccine, tested on animals since 2021, may offer a new tool in fighting COVID-19 with a non-invasive, ...

An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making it much cheaper for the ...

Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage ...

A NEW medication has been approved for the treatment of depression in a third of those who find antidepressants alone are not enough.

Experience nasal discomfort? Learn why your nose hurts when you press it or touch it and discover ways to alleviate nasal tenderness effectively.

A drug derived from ketamine will be added to the PBS, helping tens of thousands of Australians struggling with depression to ...

A new nasal spray that uses a form of ketamine to treat stubborn depression will be added to the PBS, making treatment ...